Epidemiology
Etiology
- Pathogen: Nocardia species (ubiquitous in soil worldwide)
- Reservoir: soil
- Gram positive with branching filaments
- Aerobe
- Weakly acid-fast staining (Ziehl-Neelsen stain) c

- Catalase positive
- Risk factors
Pathophysiology
Clinical features
Pulmonary nocardiosis
- Risk group: immunocompromised individuals
- Clinical features
- Constitutional: fever, weight loss, anorexia, night sweats
- Respiratory (recurrent pneumonia): productive cough, dyspnea, pleuritic chest pain
- Pulmonary nocardiosis symptoms such as fever, chills, and weight loss are often mistaken for tuberculosis
Diagnostics
Treatment
- First-line Tx:
- TMP-SMX high-dose (15-20 mg/kg/day of TMP component, IV or PO depending on severity). c
- Severe, Disseminated, or CNS Disease:
- Combination therapy: TMP-SMX + Amikacin AND/OR a Carbapenem (e.g., Imipenem or Meropenem).
- Duration of Therapy:
- Cutaneous: 3 months.
- Pulmonary: At least 6 months (immunocompetent).
- Immunocompromised or CNS disease: At least 12 months to prevent relapse.
- Surgical Management:
- Drainage/resection of large empyemas or brain abscesses not responding to medical Tx.